These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26299985)

  • 21. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-κB and systemic lupus erythematosus: examining the link.
    Zubair A; Frieri M
    J Nephrol; 2013; 26(6):953-9. PubMed ID: 23807646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting interferons and their pathways in systemic lupus erythematosus.
    Chasset F; Arnaud L
    Autoimmun Rev; 2018 Jan; 17(1):44-52. PubMed ID: 29108825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial function and its implications for cardiovascular and renal disease in systemic lupus erythematosus.
    Clancy R; Ginzler EM
    Rheum Dis Clin North Am; 2010 Feb; 36(1):145-60, ix-x. PubMed ID: 20202596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The innate immune system in human systemic lupus erythematosus.
    Weidenbusch M; Kulkarni OP; Anders HJ
    Clin Sci (Lond); 2017 Apr; 131(8):625-634. PubMed ID: 28351959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
    Roman MJ; Shanker BA; Davis A; Lockshin MD; Sammaritano L; Simantov R; Crow MK; Schwartz JE; Paget SA; Devereux RB; Salmon JE
    N Engl J Med; 2003 Dec; 349(25):2399-406. PubMed ID: 14681505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease in systemic lupus erythematosus: has the time for action come?
    van Leuven SI; Kastelein JJ; Hayden MR; d'Cruz D; Hughes GR; Stroes ES
    Curr Opin Lipidol; 2005 Oct; 16(5):501-6. PubMed ID: 16148533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
    Lorenz G; Anders HJ
    Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.
    López-Pedrera C; Aguirre MÁ; Barbarroja N; Cuadrado MJ
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20936125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.
    Kahlenberg JM; Kaplan MJ
    Arthritis Res Ther; 2011 Feb; 13(1):203. PubMed ID: 21371346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mohan C; Putterman C
    Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.
    Reiss AB
    Curr Rheumatol Rep; 2009 Aug; 11(4):255-60. PubMed ID: 19691928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.